| ABVX Abivax SA-ADR | 9.41% | 1,394,019 | $155.2M | Add +5.8% |
| PTGX Protagonist Therapeutics Inc. | 6.35% | 994,119 | $104.8M | Reduce -5.3% |
| ROIV Roivant Sciences Ltd. | 5.52% | 3,285,906 | $91.0M | Reduce -4.2% |
| IMVT Immunovant Inc. | 4.03% | 2,679,010 | $66.5M | Add +8.0% |
| SPY SS SPDR S&P 500 ETF Trust-US | 2.99% | 75,940 | $49.4M | Add +38.9% |
| TERN Terns Pharmaceuticals Inc. | 2.92% | 914,699 | $48.2M | Add +68.9% |
| CYTK Cytokinetics Inc. | 2.53% | 632,556 | $41.7M | Add +17.1% |
| CRNX Crinetics Pharmaceuticals Inc. | 2.51% | 1,139,331 | $41.4M | Add +268.3% |
| BOXX Alpha Architect 1-3 MNTH Box | 2.38% | 337,125 | $39.2M | No change |
| DNLI Denali Therapeutics Inc. | 2.18% | 1,871,455 | $35.9M | Add +3490.9% |
| BEAM Beam Therapeutics Inc. | 2.09% | 1,446,375 | $34.5M | New |
| ZLAB Zai Lab Ltd.-ADR | 1.63% | 1,425,367 | $26.8M | Add +14.3% |
| SEPN Septerna Inc. | 1.59% | 1,089,818 | $26.2M | Reduce -5.9% |
| VIR Vir Biotechnology Inc. | 1.49% | 2,744,714 | $24.6M | New |
| DBVT DBV Technologies SA-Spon ADR | 1.28% | 1,012,866 | $21.2M | New |
| AVR Anteris Technologies Global | 1.27% | 3,789,132 | $21.0M | Add +205.9% |
| INSP Inspire Medical Systems Inc. | 1.27% | 405,197 | $20.9M | Add +2601.3% |
| SRRK Scholar Rock Holding Corp. | 1.21% | 407,273 | $20.0M | Add +485.3% |
| RYTM Rhythm Pharmaceuticals Inc. | 1.11% | 211,450 | $18.4M | Add +311.8% |
| SYRE Spyre Therapeutics Inc. | 1.03% | 338,323 | $17.1M | Add +893.6% |
| CTMX Cytomx Therapeutics Inc. | 0.97% | 3,410,190 | $16.0M | Reduce -18.5% |
| PRTA Prothena Corp. PLC | 0.93% | 1,581,443 | $15.4M | Add +8.5% |
| SNY Sanofi-ADR | 0.93% | 316,939 | $15.3M | Add +399.3% |
| PCVX Vaxcyte Inc. | 0.91% | 259,137 | $15.1M | Reduce -17.9% |
| MNPR Monopar Therapeutics Inc. | 0.88% | 264,278 | $14.5M | Add +13.0% |
| ABUS Arbutus Biopharma Corp. | 0.85% | 3,133,175 | $14.1M | Reduce -42.1% |
| AMLX Amylyx Pharmaceuticals Inc. | 0.84% | 1,000,604 | $13.9M | Add +12.4% |
| CLDX Celldex Therapeutics Inc. | 0.82% | 427,816 | $13.6M | Reduce -33.9% |
| TSHA Taysha Gene Therapies Inc. | 0.81% | 2,979,429 | $13.3M | Add +19.4% |
| XENE Xenon Pharmaceuticals Inc. | 0.81% | 228,899 | $13.3M | Add +12.2% |
| STRO Sutro Biopharma Inc. | 0.79% | 524,441 | $13.1M | Add +681.9% |
| RVMD Revolution Medicines Inc. | 0.79% | 133,893 | $13.0M | Reduce -7.7% |
| ELVN Enliven Therapeutics Inc. | 0.78% | 329,540 | $12.9M | Add +998.5% |
| CGON CG Oncology Inc. | 0.76% | 185,699 | $12.6M | Reduce -28.1% |
| BIL SS SPDR BB 1-3M T-Bill ETF | 0.75% | 135,585 | $12.4M | No change |
| ESTA Establishment Labs Holdings | 0.73% | 213,473 | $12.1M | Add +24.5% |
| REPL Replimune Group Inc. | 0.73% | 1,582,987 | $12.1M | Add +27.5% |
| IVA Inventiva SA - ADR | 0.73% | 2,174,398 | $12.1M | Reduce -19.8% |
| IONS Ionis Pharmaceuticals Inc. | 0.73% | 160,338 | $12.0M | Add +9.0% |
| NKTR Nektar Therapeutics | 0.70% | 161,252 | $11.6M | Add +123.9% |
| IKT Inhibikase Therapeutics Inc. | 0.67% | 6,606,572 | $11.1M | Reduce -18.1% |
| SPRY Ars Pharmaceuticals Inc. | 0.66% | 1,361,536 | $10.9M | Add +268.4% |
| HLXC Helix Acquisition Corp. Class A | 0.62% | 1,000,000 | $10.3M | New |
| OVID Ovid Therapeutics Inc. | 0.61% | 4,544,113 | $10.1M | Add +6.0% |
| OKUR Onkure Therapeutics Inc. Class A | 0.61% | 2,434,941 | $10.1M | Add +140.1% |
| REGN Regeneron Pharmaceuticals | 0.57% | 12,154 | $9.4M | Add +0.8% |
| MLTX Moonlake Immunotherapeutics | 0.52% | 457,137 | $8.5M | New |
| LXEO Lexeo Therapeutics Inc. | 0.51% | 1,467,350 | $8.4M | Add +5.3% |
| IRD Opus Genetics Inc. | 0.51% | 1,849,004 | $8.4M | Add +4522.5% |
| TEVA Teva Pharmaceutical-SP ADR | 0.49% | 268,391 | $8.1M | Add +13.7% |
| SVRA Savara Inc. | 0.48% | 1,464,535 | $8.0M | Add +4.2% |
| MPLT Maplight Therapeutics Inc. | 0.46% | 374,909 | $7.6M | New |
| LONA Leonabio Inc. | 0.45% | 727,481 | $7.5M | Add +84.8% |
| EQ Equillium Inc. | 0.45% | 3,726,659 | $7.5M | Reduce -33.5% |
| VKTX Viking Therapeutics Inc. | 0.45% | 227,717 | $7.4M | Add +759.5% |
| DMRA Damora Therapeutics Inc. | 0.44% | 279,000 | $7.2M | New |
| URGN Urogen Pharma Ltd. | 0.43% | 395,459 | $7.1M | Add +215.4% |
| BBIO Bridgebio Pharma Inc. | 0.42% | 94,292 | $7.0M | Reduce -55.8% |
| PRME Prime Medicine Inc. | 0.42% | 1,973,282 | $6.9M | New |
| VRTX Vertex Pharmaceuticals Inc. | 0.41% | 15,075 | $6.7M | Add +9.9% |
| KRRO Korro Bio Inc. | 0.37% | 540,054 | $6.1M | New |
| VRDN Viridian Therapeutics Inc. | 0.36% | 304,422 | $6.0M | Add +294.3% |
| DHR Danaher Corp. | 0.36% | 30,932 | $5.9M | Add +20.8% |
| INSM Insmed Inc. | 0.35% | 35,392 | $5.8M | New |
| ASND Ascendis Pharma A/S | 0.35% | 25,014 | $5.7M | Reduce -1.2% |
| BHF Brighthouse Financial Inc. | 0.35% | 95,523 | $5.7M | No change |
| SRPT Sarepta Therapeutics Inc. | 0.35% | 262,058 | $5.7M | Add +807.8% |
| OACCU Oaktree Acquisition III Life | 0.33% | 516,482 | $5.5M | No change |
| FRNM Freenome Inc. filed as PERCEPTIVE CAP SOLUTIONS COR | 0.33% | 499,581 | $5.5M | Add +9.4% |
| KRYS Krystal Biotech Inc. | 0.31% | 20,014 | $5.2M | No change |
| ABOS Acumen Pharmaceuticals Inc. | 0.31% | 2,156,334 | $5.1M | Add +142.0% |
| IVVD Invivyd Inc. | 0.30% | 3,822,427 | $5.0M | Reduce -2.0% |
| BHAVU Bhav Acquisition Corp. | 0.30% | 495,000 | $4.9M | New |
| TARA Protara Therapeutic Inc. | 0.30% | 940,512 | $4.9M | Reduce -17.3% |
| AGIO Agios Pharmaceuticals Inc. | 0.29% | 140,672 | $4.8M | Reduce -25.2% |
| LLY Eli Lilly & Co. | 0.28% | 5,060 | $4.7M | New |
| DNTH Dianthus Therapeutics Inc. | 0.28% | 55,000 | $4.6M | New |
| ARWR Arrowhead Pharmaceuticals Inc. | 0.27% | 70,300 | $4.4M | Add +20.8% |
| BLTE Belite Bio Inc. - ADR | 0.26% | 26,880 | $4.3M | Reduce -32.5% |
| EVMN Evommune Inc. | 0.26% | 184,062 | $4.2M | No change |
| MLYS Mineralys Therapeutics Inc. | 0.25% | 154,686 | $4.2M | Add +13.6% |
| JANX Janux Therapeutics Inc. | 0.25% | 298,546 | $4.1M | Add +21.6% |
| CLYM Climb Bio Inc. | 0.25% | 597,662 | $4.1M | Reduce -58.3% |
| PALI Palisade Bio Inc. | 0.24% | 2,264,845 | $4.0M | Add +13.0% |
| AEXA American Exceptionalism Class A | 0.23% | 357,539 | $3.9M | No change |
| SPRB Spruce Biosciences Inc. | 0.23% | 58,600 | $3.8M | Add +1.0% |
| NAMS Newamsterdam Pharma Co. NV | 0.23% | 118,623 | $3.8M | No change |
| ZURA Zura Bio Ltd. | 0.23% | 630,403 | $3.8M | Add +12.2% |
| ACLX Arcellx Inc. | 0.22% | 32,084 | $3.7M | Add +1.9% |
| CTNM Contineum Therapeutics Inc. Class A | 0.22% | 276,661 | $3.6M | Reduce -0.8% |
| GLUE Monte Rosa Therapeutics Inc. | 0.22% | 215,752 | $3.5M | No change |
| ONC Beone Medicines Ltd.-ADR | 0.21% | 11,701 | $3.5M | New |
| TENX Tenax Therapeutics Inc. | 0.21% | 213,462 | $3.4M | Add +235.3% |
| AVBP Arrivent Biopharma Inc. | 0.20% | 141,814 | $3.3M | New |
| PLRX Pliant Therapeutics Inc. | 0.20% | 2,585,126 | $3.3M | Add +3402.0% |
| ATAI Ataibeckley Inc. | 0.20% | 913,242 | $3.2M | No change |
| RLMD Relmada Therapeutics Inc. | 0.19% | 451,918 | $3.1M | Add +1364.1% |
| CATX Perspective Therapeutics Inc. | 0.19% | 749,335 | $3.1M | Add +687.2% |
| CRBP Corbus Pharmaceuticals Holdi | 0.19% | 331,781 | $3.1M | Add +15.7% |
| ELDN Eledon Pharmaceuticals Inc. | 0.18% | 974,421 | $3.0M | Reduce -46.5% |
| PHVS Pharvaris NV | 0.18% | 105,528 | $3.0M | Add +23.4% |
| APLS Apellis Pharmaceuticals Inc. | 0.18% | 72,500 | $2.9M | Add +262.5% |
| EWTX Edgewise Therapeutics Inc. | 0.17% | 90,599 | $2.9M | Reduce -0.4% |
| PEPG Pepgen Inc. | 0.17% | 1,607,638 | $2.8M | Add +4263.6% |
| CAPR Capricor Therapeutics Inc. | 0.17% | 90,593 | $2.8M | New |
| MASI Masimo Corp. | 0.16% | 15,000 | $2.7M | No change |
| INO Inovio Pharmaceuticals Inc. | 0.16% | 1,470,108 | $2.6M | Reduce -1.0% |
| TFX Teleflex Inc. | 0.15% | 21,186 | $2.5M | Reduce -73.7% |
| DRUG Bright Minds Biosciences Inc. | 0.15% | 33,900 | $2.5M | Add +868.6% |
| BIOA Bioage Labs Inc. | 0.14% | 135,560 | $2.4M | No change |
| ALEC Alector Inc. | 0.14% | 1,050,000 | $2.3M | Reduce -5.2% |
| PFE Pfizer Inc. | 0.13% | 77,400 | $2.2M | Add +6.9% |
| DCTH Delcath Systems Inc. | 0.13% | 224,385 | $2.1M | No change |
| BIIB Biogen Inc. | 0.12% | 11,000 | $2.0M | Reduce -54.7% |
| CNTB Connect Biopharma Holdings L | 0.12% | 742,400 | $1.9M | New |
| SMMT Summit Therapeutics Inc. | 0.11% | 91,869 | $1.7M | No change |
| GMED Globus Medical Inc. Class A | 0.10% | 20,100 | $1.7M | No change |
| ALKS Alkermes PLC | 0.10% | 46,400 | $1.6M | Reduce -27.2% |
| SLNO Soleno Therapeutics Inc. | 0.10% | 46,830 | $1.6M | Add +11.9% |
| CCIIU Cohen Circle Acquisition Cor | 0.09% | 150,000 | $1.6M | No change |
| RCKT Rocket Pharmaceuticals Inc. | 0.09% | 432,500 | $1.5M | Reduce -9.1% |
| SUPN Supernus Pharmaceuticals Inc. | 0.09% | 29,642 | $1.5M | Reduce -0.3% |
| CNTA Centessa Pharmaceuticals Ltd. | 0.09% | 38,566 | $1.5M | No change |
| FOLD Amicus Therapeutics Inc. | 0.09% | 105,000 | $1.5M | New |
| MAZE Maze Therapeutics Inc. | 0.09% | 50,095 | $1.5M | Reduce -72.1% |
| UNH Unitedhealth Group Inc. | 0.09% | 5,501 | $1.5M | New |
| ADGM Adagio Medical Holdings Inc. | 0.08% | 1,205,447 | $1.4M | Add +4.0% |
| FWRD Forward Air Corp. | 0.08% | 78,241 | $1.3M | Add +193.8% |
| SXT Sensient Technologies Corp. | 0.08% | 15,000 | $1.3M | New |
| KNSA Kiniksa Pharmaceuticals Inte | 0.08% | 26,913 | $1.3M | Reduce -6.3% |
| CRVS Corvus Pharmaceuticals Inc. | 0.08% | 87,901 | $1.3M | Reduce -81.1% |
| MSLE Satellos Bioscience Inc. | 0.08% | 222,555 | $1.3M | New |
| QURE Uniqure NV | 0.08% | 76,206 | $1.2M | Reduce -67.6% |
| NVO Novo-Nordisk A/S-Spons ADR | 0.07% | 33,000 | $1.2M | New |
| PMN Promis Neurosciences Inc. | 0.07% | 95,350 | $1.2M | New |
| LXRX Lexicon Pharmaceuticals Inc. | 0.07% | 750,000 | $1.2M | New |
| SDGR Schrodinger Inc. | 0.07% | 101,500 | $1.2M | New |
| XNCR Xencor Inc. | 0.07% | 93,665 | $1.1M | Add +66.8% |
| OABI Omniab Inc. | 0.07% | 705,190 | $1.1M | Add +0.4% |
| FDMT 4D Molecular Therapeutics Inc. | 0.07% | 116,712 | $1.1M | No change |
| KROS Keros Therapeutics Inc. | 0.07% | 97,318 | $1.1M | Add +416.3% |
| DAWN Day One Biopharmaceuticals I | 0.06% | 49,923 | $1.1M | New |
| BMY Bristol-Myers Squibb Co. | 0.06% | 17,500 | $1.1M | Reduce -12.5% |
| TNGX Tango Therapeutics Inc. | 0.06% | 50,000 | $1.0M | Reduce -64.3% |
| TNYA Tenaya Therapeutics Inc. | 0.06% | 1,507,800 | $1.0M | Add +0.2% |
| BSAAU Best Spac I Acquisition Corp. | 0.06% | 100,000 | $1.0M | No change |
| MCK McKesson Corp. | 0.06% | 1,200 | $1.0M | No change |
| BMRN Biomarin Pharmaceutical Inc. | 0.06% | 18,200 | $1.0M | Add +41.1% |
| ORKA Oruka Therapeutics Inc. | 0.06% | 20,840 | $1.0M | No change |
| EA Electronic Arts Inc. | 0.06% | 4,936 | $1.0M | No change |
| FULC Fulcrum Therapeutics Inc. | 0.06% | 130,560 | $1.0M | Reduce -89.6% |
| BCRX Biocryst Pharmaceuticals Inc. | 0.06% | 105,000 | $1000K | Add +133.3% |
| GH Guardant Health Inc. | 0.06% | 10,000 | $924K | Add +42.9% |
| CBIO Crescent Biopharma Inc. | 0.06% | 50,273 | $924K | Reduce -91.7% |
| CNTX Context Therapeutics Inc. | 0.06% | 351,094 | $920K | No change |
| ENGN Engene Holdings Inc. | 0.06% | 133,686 | $910K | Reduce -56.0% |
| SLN Silence Therapeutics PLC-ADR | 0.06% | 172,157 | $907K | Add +628.1% |
| ARE Alexandria Real Estate Equit | 0.05% | 19,500 | $905K | Add +19.6% |
| IBIO Ibio Inc. | 0.05% | 469,878 | $893K | Add +15.9% |
| BNTX Biontech SE-ADR | 0.05% | 10,000 | $889K | No change |
| GILD Gilead Sciences Inc. | 0.05% | 6,351 | $885K | Reduce -4.7% |
| NRIX Nurix Therapeutics Inc. | 0.05% | 56,070 | $869K | Reduce -22.2% |
| DYN Dyne Therapeutics Inc. | 0.05% | 47,463 | $861K | Add +11.2% |
| ISRG Intuitive Surgical Inc. | 0.05% | 1,830 | $844K | Add +79.4% |
| ANL Adlai Nortye Group Ltd. | 0.05% | 117,909 | $816K | New |
| WW WW International Inc.-New filed as WW INTL INC | 0.05% | 57,700 | $793K | Add +1.1% |
| RNA Atrium Therapeutics Inc. | 0.05% | 57,688 | $771K | New |
| ITGR Integer Holdings Corp. | 0.05% | 8,750 | $770K | New |
| KPTI Karyopharm Therapeutics Inc. | 0.05% | 136,736 | $762K | Add +173.5% |
| CMPX Compass Therapeutics Inc. | 0.04% | 139,000 | $735K | No change |
| NUVL Nuvalent Inc. Class A | 0.04% | 6,942 | $711K | Add +1.5% |
| CGEM Cullinan Therapeutics Inc. | 0.04% | 50,000 | $711K | No change |
| IDYA Ideaya Biosciences Inc. | 0.04% | 20,000 | $666K | No change |
| ENTA Enanta Pharmaceuticals Inc. | 0.04% | 51,357 | $649K | Add +24.2% |
| VERA Vera Therapeutics Inc. | 0.04% | 16,033 | $645K | Add +8.8% |
| VYNE THERAPEUTICS INC | 0.04% | 1,063,899 | $636K | Add +319.2% |
| BSX Boston Scientific Corp. | 0.04% | 10,000 | $628K | Add +100.0% |
| AVTR Avantor Inc. | 0.04% | 80,000 | $627K | Add +14.3% |
| ARVN Arvinas Inc. | 0.04% | 57,591 | $610K | Reduce -0.9% |
| KZR Kezar Life Sciences Inc. | 0.04% | 81,933 | $608K | Reduce -30.2% |
| KLRS Kalaris Therapeutics Inc. | 0.04% | 100,000 | $577K | No change |
| MIRM Mirum Pharmaceuticals Inc. | 0.03% | 6,200 | $573K | New |
| JAZZ Jazz Pharmaceuticals PLC | 0.03% | 3,000 | $567K | Reduce -62.5% |
| ASMB Assembly Biosciences Inc. | 0.03% | 19,947 | $554K | Add +1.0% |
| PRLD Prelude Therapeutics Inc. | 0.03% | 152,825 | $523K | New |
| GTERU Globa Terra Acquisition Corp. | 0.03% | 50,000 | $518K | No change |
| USFR Wisdomtree Floating Rate Tre | 0.03% | 10,000 | $503K | No change |
| ACRS Aclaris Therapeutics Inc. | 0.03% | 132,426 | $497K | Reduce -78.4% |
| PRAX Praxis Precision Medicines I | 0.03% | 1,500 | $483K | No change |
| LUNG Pulmonx Corp. | 0.03% | 374,497 | $483K | Add +5.4% |
| ELAN Elanco Animal Health Inc. | 0.03% | 20,000 | $479K | No change |
| PHAT Phathom Pharmaceuticals Inc. | 0.03% | 42,900 | $477K | No change |
| MDGL Madrigal Pharmaceuticals Inc. | 0.03% | 895 | $469K | No change |
| PYPD Polypid Ltd. | 0.03% | 103,950 | $455K | No change |
| BABA Alibaba Group Holding-SP ADR | 0.03% | 3,578 | $449K | No change |
| CORZ Core Scientific Inc. | 0.03% | 30,000 | $449K | No change |
| WHWK Whitehawk Therapeutics Inc. | 0.03% | 128,503 | $443K | Add +65.6% |
| NTRA Natera Inc. | 0.03% | 2,147 | $429K | No change |
| VTGN Vistagen Therapeutics Inc. | 0.03% | 751,141 | $429K | Add +20.5% |
| TXMD Therapeuticsmd Inc. | 0.03% | 209,210 | $423K | No change |
| SNDX Syndax Pharmaceuticals Inc. | 0.02% | 17,500 | $409K | Add +45.8% |
| TECX Tectonic Therapeutic Inc. | 0.02% | 13,001 | $402K | Reduce -56.7% |
| TRDA Entrada Therapeutics Inc. | 0.02% | 30,500 | $385K | New |
| BHVN Biohaven Ltd. | 0.02% | 44,777 | $379K | Add +30.6% |
| MRK Merck & Co. Inc. | 0.02% | 3,140 | $378K | Reduce -67.4% |
| VSTM Verastem Inc. | 0.02% | 71,100 | $377K | New |
| RGNX Regenxbio Inc. | 0.02% | 44,416 | $372K | Reduce -69.3% |
| ACET Adicet Bio Inc. | 0.02% | 53,827 | $367K | Reduce -58.2% |
| LEGN Legend Biotech Corp.-ADR | 0.02% | 20,000 | $362K | New |
| SRZN Surrozen Inc. | 0.02% | 12,000 | $350K | New |
| ZNTL Zentalis Pharmaceuticals Inc. | 0.02% | 144,636 | $338K | Add +80.8% |
| BCYC Bicycle Therapeutics PLC-ADR | 0.02% | 71,298 | $331K | New |
| NBIX Neurocrine Biosciences Inc. | 0.02% | 2,500 | $329K | New |
| WVE Wave Life Sciences Ltd. | 0.02% | 44,900 | $326K | New |
| KURA Kura Oncology Inc. | 0.02% | 40,000 | $325K | No change |
| KPRX Kiora Pharmaceuticals Inc. | 0.02% | 167,941 | $324K | No change |
| CORT Corcept Therapeutics Inc. | 0.02% | 8,000 | $322K | New |
| UPB Upstream Bio Inc. | 0.02% | 35,000 | $315K | New |
| KIDS Orthopediatrics Corp. | 0.02% | 19,845 | $315K | No change |
| ANNX Annexon Inc. | 0.02% | 55,000 | $305K | Add +14.6% |
| GERN Geron Corp. | 0.02% | 200,000 | $298K | Reduce -40.5% |
| JD Jd.com Inc.-ADR | 0.02% | 10,000 | $296K | No change |
| PMVP PMV Pharmaceuticals Inc. | 0.02% | 231,008 | $286K | Add +128.7% |
| TRAW Traws Pharma Inc. | 0.02% | 154,098 | $282K | Reduce -0.2% |
| JBIO Jade Biosciences Inc. | 0.02% | 20,000 | $281K | Reduce -4.8% |
| RARE Ultragenyx Pharmaceutical Inc. | 0.02% | 13,400 | $281K | New |
| PCAPU Procap Acquisition Corp. | 0.02% | 26,940 | $279K | No change |
| BCAX Bicara Therapeutics Inc. | 0.02% | 13,705 | $273K | No change |
| RXST Rxsight Inc. | 0.02% | 43,250 | $266K | Add +98.4% |
| PANW Palo Alto Networks Inc. | 0.02% | 1,600 | $257K | New |
| NTLA Intellia Therapeutics Inc. | 0.02% | 19,517 | $250K | New |
| CRWD CrowdStrike Holdings Inc. Class A | 0.02% | 640 | $250K | New |
| RBRK Rubrik Inc. Class A | 0.01% | 4,900 | $240K | New |
| RPRX Royalty Pharma PLC Class A | 0.01% | 5,000 | $240K | New |
| SGRY Surgery Partners Inc. | 0.01% | 20,000 | $238K | No change |
| LRMR Larimar Therapeutics Inc. | 0.01% | 52,745 | $237K | Reduce -71.6% |
| EOLS Evolus Inc. | 0.01% | 55,859 | $230K | Add +55.8% |
| QTTB Q32 Bio Inc. | 0.01% | 35,000 | $225K | Add +75.0% |
| LGVN Longeveron Inc. | 0.01% | 200,000 | $208K | New |
| ANAB Anaptysbio Inc. | 0.01% | 3,698 | $205K | New |
| CEPS Cantor Equity Partners Vi -A | 0.01% | 20,000 | $202K | New |
| KALV Kalvista Pharmaceuticals Inc. | 0.01% | 10,000 | $201K | No change |
| KYTX Kyverna Therapeutics Inc. | 0.01% | 22,428 | $194K | Reduce -61.0% |
| NUVB Nuvation Bio Inc. | 0.01% | 43,500 | $187K | New |
| BNTC Benitec Biopharma Inc. | 0.01% | 17,500 | $186K | New |
| LPCN Lipocine Inc. | 0.01% | 23,180 | $185K | New |
| RLYB Rallybio Corp. | 0.01% | 20,535 | $184K | New |
| RZLT Rezolute Inc. | 0.01% | 58,679 | $179K | Add +51.7% |
| QCLS Q/C Technologies Inc. | 0.01% | 50,000 | $173K | New |
| ERAS Erasca Inc. | 0.01% | 10,000 | $162K | New |
| COYA Coya Therapeutics Inc. | 0.01% | 40,900 | $161K | New |
| PSNL Personalis Inc. | 0.01% | 25,000 | $159K | New |
| SIBN Si-Bone Inc. | 0.01% | 12,580 | $159K | New |
| STLN Starling Oncology Inc. filed as THE ONCOLOGY INSTITUTE INC | 0.01% | 50,000 | $154K | New |
| HELP Cybin Inc. | 0.01% | 31,278 | $150K | Reduce -86.9% |
| STIM Neuronetics Inc. | 0.01% | 100,000 | $145K | New |
| ARDX Ardelyx Inc. | 0.01% | 23,900 | $143K | New |
| IFRX Inflarx NV | 0.01% | 158,271 | $142K | New |
| ACHV Achieve Life Sciences Inc. | 0.01% | 47,800 | $141K | No change |
| VYGR Voyager Therapeutics Inc. | 0.01% | 35,000 | $135K | No change |
| CMMB Chemomab Therapeutics Ltd. | 0.01% | 80,000 | $126K | No change |
| JSPR Jasper Therapeutics Inc. | 0.01% | 140,000 | $123K | No change |
| NEUP Neuphoria Therapeutics Inc. | 0.01% | 30,000 | $122K | No change |
| MIST Milestone Pharmaceuticals Inc. | 0.01% | 100,000 | $119K | Reduce -0.1% |
| ARCT Arcturus Therapeutics Holdin | 0.01% | 15,000 | $116K | New |
| MGNX Macrogenics Inc. | 0.01% | 40,000 | $116K | New |
| CCCC C4 Therapeutics Inc. | 0.01% | 43,000 | $113K | New |
| RXRX Recursion Pharmaceuticals-A | 0.01% | 35,000 | $107K | No change |
| DSGN Design Therapeutics Inc. | 0.01% | 10,000 | $106K | New |
| GOSS Gossamer Bio Inc. | 0.01% | 287,531 | $94K | Add +35.3% |
| IMMX Immix Biopharma Inc. | 0.01% | 10,000 | $91K | Reduce -80.0% |
| LITS Lite Strategy Inc. | 0.00% | 67,292 | $78K | No change |
| VERU Veru Inc. | 0.00% | 35,000 | $77K | No change |
| KYNB Kyntra Bio Inc. | 0.00% | 10,469 | $71K | No change |
| CLOV Clover Health Investments Co. | 0.00% | 40,000 | $70K | Reduce -17.2% |
| BMEA Biomea Fusion Inc. | 0.00% | 43,420 | $66K | No change |
| NMRA Neumora Therapeutics Inc. | 0.00% | 33,100 | $65K | Reduce -34.6% |
| OGN Organon & Co. | 0.00% | 10,000 | $60K | Reduce -71.4% |
| ESPR Esperion Therapeutics Inc. | 0.00% | 21,400 | $59K | New |
| MREO Mereo Biopharma Group PL-ADR | 0.00% | 150,000 | $50K | No change |
| ANTX AN2 Therapeutics Inc. | 0.00% | 13,861 | $47K | New |
| AQST Aquestive Therapeutics Inc. | 0.00% | 10,000 | $42K | New |
| ATYR Atyr Pharma Inc. | 0.00% | 50,685 | $40K | No change |
| BCAB Bioatla Inc. | 0.00% | 228,107 | $37K | Add +24.6% |
| KALA Kala Bio Inc. | 0.00% | 141,480 | $24K | No change |
| CHRS Coherus Oncology Inc. | 0.00% | 10,366 | $18K | No change |
| PRQR Proqr Therapeutics NV | 0.00% | 10,000 | $16K | No change |
| ARROWHEAD RESEARCH CORP (ARWR 0 01/15/32) | 0.00% | 10,000 | $10K | New |
| QUINCE THERAPEUTICS INC | 0.00% | 50,100 | $5K | Add +16.8% |
| IMUX Immunic Inc. | 0.00% | 30,000 | $0 | New |